期刊文献+

老年慢性肾脏病患者骨质疏松发生情况与危险因素 被引量:5

The incidence and risk factors of osteoporosis in elderly patients with chronic kidney disease
下载PDF
导出
摘要 目的分析老年慢性肾脏病(CKD)患者并发骨质疏松症后骨密度(BMD)的改变及其与各种危险因素的相关性,为早期诊断、早期防治CKD并发骨质疏松症提供理论依据。方法年龄65岁以上非透析的CKD住院患者,根据2002年K/DOQI指南CKD的定义及分期系统分为CKD 1~2期组、CKD 3期组和CKD 4~5期组。记录临床特征,实验室检查指标,并行双能X线骨密度测量法测定腰椎及股骨BMD。根据受试者的BMD值将CKD患者分为骨质疏松组(OP组)和非骨质疏松组(非OP组),对比两组CKD患者的性别、年龄、体质量指数(BMI)、血清钙、磷及骨钙素之间的差异,分析其危险因素。结果老年CKD患者骨质疏松发生率高达30.4%,OP组与非OP组比较,女性比率大,BMI及维生素D水平低,血清降钙素水平高。两组间差异均有统计学意义(P〈0.05)。多因素分析,绝经后女性和低BMI是老年CKD患者骨质疏松的危险因素。结论老年CKD患者骨质疏松发生率高,其中,绝经后老年女性和低BMI的老年患者是发生骨质疏松的高危人群。 Objective To evaluate bone mineral density( BMD) and analyze the incidence and risk factors of osteoporosis in elderly patients with chronic kidney disease( CKD). Methods 151 cases of nondialyzed CKD were divided into 3 groups( CKD stages1-2,CKD stage 3and CKD stages 4-5) on the basis of Kidney Disease Outcome Quality Initiative( K /DOQI). All patients received lumbar and femoral BMD test by dual-energy X-ray absorptiometry. Based on BMD,all patients were further divided into osteoporosis group and non-osteoporosis group.Results The incidence of osteoporosis in elderly patients with CKD were 30. 4%,and more common in female patients. Compare to non-osteoporosis group,patients in osteoporosis group had significantly lower body mass index( BMI),lower blood vitamin D levels and higher serum calcitonin levels( all P〈 0. 05). Conclusion Postmenopausal and low BMI are risk factors of osteoporosis in elderly patients with CKD.
出处 《临床和实验医学杂志》 2014年第17期1411-1413,共3页 Journal of Clinical and Experimental Medicine
基金 北京市干部保健人群2型糖尿病控制现状课题资助(11-012)
关键词 老年 慢性肾脏病 骨密度 骨质疏松症 危险因素 Elderly patients Chronic kidney disease Bone mineral density Osteoporosis Risk factors
  • 相关文献

参考文献9

二级参考文献56

共引文献108

同被引文献52

  • 1刘红,廖二元,伍贤平.骨钙素与代谢性骨病[J].国外医学(内分泌学分册),2004,24(4):239-240. 被引量:44
  • 2National Kidney Foundation. K/DOQI clinical practice guidelines forbone metabolism and disease in chronic kidney disease [ J ] . Am JKidney Dis, 2003 ,42( Suppl 3) :S1 -S201.
  • 3Lewiecki EM , Watts NB. New guidelines for the prevention and treat-ment of osteoporosis [ J ]. South Med J ,2009 ,102 : 175 - 179.
  • 4Yenchek RH,Ix JH , Shlipak MG, et al. Bone mineral density andfracture risk in older individuals with CKD[ J] . Clin J Am Soc Neph-rol ,2012 ,7 (7) :1130 -1136.
  • 5Iimori S, Mori Y , Akita W, et al. Diagnostic usefulness of bone miner-al density and biochemical markers of bone turnover in predicting frac-ture in CKD stage 5 D patients—a single - center cohort study [ J ].Nephrol Dial Transplant, 2012 ,27 ( 1) :345 - 351.
  • 6Akaberi S , Simonsen 0,Lindergard B , et al. Can DXA predict frac-tures in renal transplant patients? [J]. Am J Transplant, 2008,8(12) : 2647 -2651.
  • 7Jamal SA, Bauer DC , Ensrud KE, et al. Alendronate treatment in-women with normal to severely impaired renal function : ananalysis ofthe fracture intervention trial [ J ]. J Bone Miner Res, 2007 , 22 ( 4 ):503 -508.
  • 8Miller PD, Roux C , Boonen S, et al. Safety and efficacy of risedr-onate in patients with age - relatedreduced renal function as estimatedby the Cockcroft and Gaultmethod : a pooled analysis of nine clinicaltrials[J]. J Bone Miner Res,2005 ,20( 12) :2105 -2115.
  • 9Ishani A,Blackwell T, Jamal SA,et al. The effect of raloxifene treat-ment in postmenopausal women with CKD [ J ]. J Am Soc Nephrol,2008,19(7) :1430 - 1438.
  • 10Miller PD , Schwartz EN , Chen P, et al. Teriparatide in postmenopa-usal women with osteoporosis and mild ormoderate renal impairment[J] . Osteoporos Int ,2007 ,18( 1 ) :59 - 68.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部